CoChat

Essential fatty acids: biochemistry, physiology and pathology

Das, Undurti N. · 2006 · Biotechnology Journal

The DOI matches its Crossref record; 170 of the 172 references it cites were found in a registry or an index.

Abstract

Essential fatty acids (EFAs), linoleic acid (LA), and α‐linolenic acid (ALA) are essential for humans, and are freely available in the diet. Hence, EFA deficiency is extremely rare in humans. To derive the full benefits of EFAs, they need to be metabolized to their respective long‐chain metabolites, i.e. , dihomo‐γ‐linolenic acid (DGLA), and arachidonic acid (AA) from LA; and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from ALA. Some of these long‐chain metabolites not only form precursors to respective prostaglandins (PGs), thromboxanes (TXs), and leukotrienes (LTs), but also give rise to lipoxins (LXs) and resolvins that have potent anti‐inflammatory actions. Furthermore, EFAs and their metabolites may function as endogenous angiotensin‐converting enzyme and 3‐hdroxy‐3‐methylglutaryl coenzyme A reductase inhibitors, nitric oxide (NO) enhancers, anti‐hypertensives, and anti‐atherosclerotic molecules. Recent studies revealed that EFAs react with NO to yield respective nitroalkene derivatives that exert cell‐signaling actions via ligation and activation of peroxisome proliferator‐activated receptors. The metabolism of EFAs is altered in several diseases such as obesity, hypertension, diabetes mellitus, coronary heart disease, schizophrenia, Alzheimer's disease, atherosclerosis, and cancer. Thus, EFAs and their derivatives have varied biological actions and seem to be involved in several physiological and pathological processes.

Overview

Integrity signals

Registry

Crossref · 10.1002/biot.200600012

Cites

170 of 170 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 9

  1. Das U.N., 1991, Essential fatty acids: Biology and their clinical implications., Asian Pacific J. Pharmacol., 6, 317
  2. Doyle W., 1982, Comparison of fatty acid intakes in the contrasting socio‐economic groups in pregnancy., Proc. Nutr. Soc., 42, 69A
  3. Das U.N., 1994, Insulin resistance and hyperinsulinemia: Are they secondary to an alteration in the metabolism of essential fatty acids?, Med. Sci. Res., 22, 243
  4. 10.1054/plef.2001.0311 · DOI
  5. Bunk S., 2002, ACEs wild., Scientist, 16, 22
  6. 10.1111/j.1523-1755.2005.00151.x · DOI · Paper page
  7. 10.1093/ajcn/82.2.281 · doi:10.1093/ajcn/82.2.281 · Paper page
  8. Smith E.B., 1962, The effects of age and of early atheroma on the intimal lipids in men., Biochem. J., 84, 49p
  9. 10.1007/s00125-005-0053-y · DOI · Paper page

Cited by

See all 650

Metadata

Authors
Das, U. N.
Corresponding author
Das, Undurti N.
Venue
Biotechnology Journal
Publisher
Wiley
Published
2006-04
Volume
1
Issue
4
Pages
420-439
ISSN
  • 1860-6768 (ISSN-L)
  • 1860-7314
OpenAlex
W2077699493
Cited by
650
References
172
Citations by year
2026: 20 · 2025: 30 · 2024: 43 · 2023: 33 · 2022: 31 · 2021: 38 · 2020: 34 · 2019: 25 · 2018: 31 · 2017: 31 · 2016: 22 · 2015: 30 · 2014: 34 · 2013: 42 · 2012: 41
FWCI
3.10
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
essential fatty acids, linoleic acid, alpha-linolenic acid, long-chain polyunsaturated fatty acids, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, dihomo-gamma-linolenic acid, prostaglandins, thromboxane, leukotrienes, lipoxins, resolvins, nitric oxide, nitroalkenes, peroxisome proliferator-activated receptors, anti-inflammatory activity, obesity, hypertension, diabetes mellitus, coronary artery disease, Alzheimer's disease, schizophrenia, atherosclerosis, cancer
MeSH terms
Animals, Dietary Fats, Fatty Acids, Essential, Humans, Inflammation, Metabolic Diseases, Nervous System Diseases, Obesity, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.